Hyaluronic Acid: biomarker evidence

Hyaluronic Acid appears in 1 entry of the OSMF biomarker atlas, covering Osteoarthritis. Across those entries it is reduced in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Osteoarthritis

Where Hyaluronic Acid is reported

ConditionDirectionCompared againstAssociated symptomsSource
Osteoarthritis↓ reducedOA synovial fluid vs normal—Moskowitz et al. 2000

Frequently asked questions

In which conditions is Hyaluronic Acid altered?

In the OSMF atlas Hyaluronic Acid is reported in Osteoarthritis. It is reduced in 1 across 1 entries.

Is there a standard clinical test for Hyaluronic Acid?

The atlas entries for Hyaluronic Acid do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Hyaluronic Acid result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Hyaluronic Acid across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/hyaluronic-acid.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.